找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Advances in Immunity and Cancer Therapy; Volume 1 P. K. Ray Book 1985 Springer-Verlag New York, Inc. 1985 Antigen.Immunologie.Krebs.interfe

[復(fù)制鏈接]
查看: 45208|回復(fù): 38
樓主
發(fā)表于 2025-3-21 17:17:39 | 只看該作者 |倒序瀏覽 |閱讀模式
期刊全稱Advances in Immunity and Cancer Therapy
期刊簡稱Volume 1
影響因子2023P. K. Ray
視頻videohttp://file.papertrans.cn/149/148324/148324.mp4
學(xué)科分類Advances in Immunity and Cancer Therapy
圖書封面Titlebook: Advances in Immunity and Cancer Therapy; Volume 1 P. K. Ray Book 1985 Springer-Verlag New York, Inc. 1985 Antigen.Immunologie.Krebs.interfe
影響因子The rapid and continuous upsurge of interesting data in the subject of tumor immunology necessitates the publication of an annual series to furnish the updated materials to the students, researchers, and clinicians in this rapidly advancing field. Concepts and methodologies are ever changing. Also, current research in tumor immunology promises to offer breakthroughs in the future. Important is the need to communicate to the right people the exact role of immunodiagnostic methods and immunolog- ical intervention in cancer prevention and treatment. The role of immuno- therapy in combination with conventional modalities of treatment needs in its proper perspective. Oncogene, interferon, lympho- to be understood kines, monoclonal antibodies, natural killer cells, platelet-mediated cyto- toxicity of antibody-coated target cells, suppressor cells, platelet-derived factors, plasma-blocking factors, control of suppressor cell function, ab- rogation of plasma-blocking factors, etc. , are some of the areas that are continually advancing. Progress in these areas will have implication in cancer therapy. Further, it is already understood that if immunocompe- tence of the host can be maintained
Pindex Book 1985
The information of publication is updating

書目名稱Advances in Immunity and Cancer Therapy影響因子(影響力)




書目名稱Advances in Immunity and Cancer Therapy影響因子(影響力)學(xué)科排名




書目名稱Advances in Immunity and Cancer Therapy網(wǎng)絡(luò)公開度




書目名稱Advances in Immunity and Cancer Therapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Advances in Immunity and Cancer Therapy被引頻次




書目名稱Advances in Immunity and Cancer Therapy被引頻次學(xué)科排名




書目名稱Advances in Immunity and Cancer Therapy年度引用




書目名稱Advances in Immunity and Cancer Therapy年度引用學(xué)科排名




書目名稱Advances in Immunity and Cancer Therapy讀者反饋




書目名稱Advances in Immunity and Cancer Therapy讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

1票 100.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:46:19 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:29:30 | 只看該作者
Cells Responsible for Tumor Surveillance in Man: Effects of Radiotherapy, Chemotherapy, and Biologilarly due the 3D and spatial information obtained. Cardiac catheterization with angiography is utilized less as a solely diagnostic technique, but has a substantial and increasing role in non-surgical intervention for CHD. Genetic testing in pediatric cardiology is adding yet further information reg
地板
發(fā)表于 2025-3-22 05:33:34 | 只看該作者
Immunity and Its Role in Conventional Cancer Therapy,o cardiac lineage or paracrine effects as potential modes of action of stem cells in HF has been discussed. Finally, the routes of administration, cell dose and cell survival, and long-term engraftment have been discussed as current challenges and future directions. The purpose of this chapter is to
5#
發(fā)表于 2025-3-22 11:17:30 | 只看該作者
Immunologic Methods of Diagnostic and Prognostic Value in Tumor Bearers,proctological conditions, while others may open up new paths for future research. In addition, in colo-proctology as in other disciplines, advances in treatment almost always bring new problems in the complications which attend them. These are the subject of some of the papers. Although it would be invidious 978-3-540-55327-4978-3-642-51680-1
6#
發(fā)表于 2025-3-22 14:56:04 | 只看該作者
7#
發(fā)表于 2025-3-22 17:38:08 | 只看該作者
8#
發(fā)表于 2025-3-22 23:40:56 | 只看該作者
9#
發(fā)表于 2025-3-23 01:57:27 | 只看該作者
10#
發(fā)表于 2025-3-23 06:32:32 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-17 09:16
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
渭源县| 西宁市| 仙游县| 河西区| 大城县| 郑州市| 巧家县| 临海市| 宜春市| 咸阳市| 治多县| 昆明市| 井研县| 长岛县| 铜山县| 娱乐| 海林市| 凌海市| 高雄县| 应城市| 博爱县| 伊川县| 廉江市| 峡江县| 昌江| 武隆县| 霞浦县| 大厂| 上杭县| 沭阳县| 久治县| 伊金霍洛旗| 新昌县| 建平县| 新丰县| 南郑县| 罗城| 凤城市| 阜平县| 湄潭县| 尼勒克县|